Abbott Laboratories (ABT) Tops Q1 EPS by 5c; Reaffirms FY14 Outlook
Tweet
Share
E-mailGet Alerts ABT Hot Sheet
Price: $102.23 -0.13%
Revenue Growth %: +14.2%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: +14.2%
Financial Fact:
Total Operating Cost and Expenses: 4.41B
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Abbott Laboratories (NYSE: ABT) reported Q1 ongoing EPS of $0.41, $0.05 better than the analyst estimate of $0.36. Revenue for the quarter came in at $5.24 billion versus the consensus estimate of $5.29 billion.
Abbott reaffirmed FY2014 guidance.
For earnings history and earnings-related data on Abbott Laboratories (ABT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- McDonald’s said to plan value strategy overhaul to revive US sales growth
- Investec Double Upgrades Supreme Industries (SI:IN) to Buy
- UBS Upgrades Kyocera (6971:JP) (KYOCY) to Buy
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
